Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03435055 · ClinicalTrials.gov registry record · Phase 4
Network-Level Effects of Nitrous Oxide in the Human Brain
A Phase 4 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 4
- Development phase
- 21
- Enrollment target
NCT03435055 is a Phase 4 study that has completed, run by University of Michigan. The registered enrollment target is 21 participants.
The verdict
NCT03435055, a Phase 4 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to understand how a commonly used drug, nitrous oxide, acts on the brain to reduce pain. Nitrous oxide is commonly used in anesthesiology but there is limited knowledge on how this drug affects functional networks in the brain.
Interventions
- DRUG Nitrous Oxide Gas for Inhalation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-07-21 |
| Est. Completion | 2019-10-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03435055
The ClinicalTrials.gov registry entry for NCT03435055 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nitrous Oxide Gas for Inhalation is the first listed.
NCT03435055 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03435055 about?
NCT03435055 is a clinical study titled "Network-Level Effects of Nitrous Oxide in the Human Brain". The purpose of this study is to understand how a commonly used drug, nitrous oxide, acts on the brain to reduce pain. Nitrous oxide is commonly used in anesthesiology but there is limited knowledge on how this drug affects functional networks in the brain.
What is the current status of trial NCT03435055?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2017-07-21. Estimated completion is 2019-10-11.
What interventions are being tested in trial NCT03435055?
The interventions under investigation include: Nitrous Oxide Gas for Inhalation (DRUG).
Who is sponsoring clinical trial NCT03435055?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.